These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 31348919)

  • 1. A selective peroxisome proliferator-activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress.
    Mirza R; Sharma B
    Chem Biol Interact; 2019 Sep; 311():108758. PubMed ID: 31348919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective modulator of peroxisome proliferator-activated receptor-α protects propionic acid induced autism-like phenotypes in rats.
    Mirza R; Sharma B
    Life Sci; 2018 Dec; 214():106-117. PubMed ID: 30366038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-γ agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats.
    Mirza R; Sharma B
    Int J Dev Neurosci; 2019 Aug; 76():6-16. PubMed ID: 31128204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
    Mirza R; Sharma B
    Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guggulsterone Mediated JAK/STAT and PPAR-Gamma Modulation Prevents Neurobehavioral and Neurochemical Abnormalities in Propionic Acid-Induced Experimental Model of Autism.
    Khera R; Mehan S; Bhalla S; Kumar S; Alshammari A; Alharbi M; Sadhu SS
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ameliorating effect of pioglitazone on prenatal valproic acid-induced behavioral and neurobiological abnormalities in autism spectrum disorder in rats.
    Sandhu A; Rawat K; Gautam V; Bhatia A; Grover S; Saini L; Saha L
    Pharmacol Biochem Behav; 2024 Apr; 237():173721. PubMed ID: 38307465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shielding Effect of Ryanodine Receptor Modulator in Rat Model of Autism.
    Kumar H; Kulkarni GT; Diwan V; Sharma B
    Basic Clin Neurosci; 2023; 14(2):247-261. PubMed ID: 38107532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of PPAR gamma agonist in rat model of autism spectrum disorder: Role of Wnt/β-catenin pathway.
    Sandhu A; Rawat K; Gautam V; Kumar A; Sharma A; Bhatia A; Grover S; Saini L; Saha L
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Dec; 135():111126. PubMed ID: 39179196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR-γ agonist, pioglitazone, reduced oxidative and endoplasmic reticulum stress associated with L-NAME-induced hypertension in rats.
    Soliman E; Behairy SF; El-Maraghy NN; Elshazly SM
    Life Sci; 2019 Dec; 239():117047. PubMed ID: 31730865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of PPAR-γ agonist, pioglitazone on brain tissues oxidative damage and learning and memory impairment in juvenile hypothyroid rats.
    Baghcheghi Y; Salmani H; Beheshti F; Shafei MN; Sadeghnia HR; Soukhtanloo M; Ebrahimzadeh Bideskan A; Hosseini M
    Int J Neurosci; 2019 Oct; 129(10):1024-1038. PubMed ID: 31215278
    [No Abstract]   [Full Text] [Related]  

  • 11. Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.
    Luhach K; Kulkarni GT; Singh VP; Sharma B
    J Pharm Pharmacol; 2021 Oct; 73(11):1460-1469. PubMed ID: 34459916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxiracetam and Zinc Ameliorates Autism-Like Symptoms in Propionic Acid Model of Rats.
    Paudel R; Raj K; Gupta YK; Singh S
    Neurotox Res; 2020 Apr; 37(4):815-826. PubMed ID: 32026359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propionic acid induced behavioural effects of relevance to autism spectrum disorder evaluated in the hole board test with rats.
    Meeking MM; MacFabe DF; Mepham JR; Foley KA; Tichenoff LJ; Boon FH; Kavaliers M; Ossenkopp KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109794. PubMed ID: 31639413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of papaverine on developmental hyperserotonemia induced autism spectrum disorder related behavioural phenotypes by altering markers of neuronal function, inflammation, and oxidative stress in rats.
    Luhach K; Kulkarni GT; Singh VP; Sharma B
    Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):614-625. PubMed ID: 33480092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of single and combined PPAR-α and PPAR-γ activation on the neurological outcomes following cerebral ischemia reperfusion.
    Shehata AHF; Ahmed AF; Abdelrehim AB; Heeba GH
    Life Sci; 2020 Jul; 252():117679. PubMed ID: 32325134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder.
    Kumar H; Sharma BM; Sharma B
    Neurochem Int; 2015 Dec; 91():34-45. PubMed ID: 26498253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of propionic acid-induced autism spectrum disorder in rats through dapagliflozin: The role of IGF-1/IGFBP-3 and the Nrf2 antioxidant pathway.
    Erdogan MA; Nesil P; Altuntas I; Sirin C; Uyanikgil Y; Erbas O
    Neuroscience; 2024 Aug; 554():16-25. PubMed ID: 39004410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal exposure to propionic acid induces altered locomotion and reactive astrogliosis in male rats.
    González-Cano SI; Camacho-Abrego I; Diaz A; de la Cruz F; Morales-Medina JC; Flores G
    J Chem Neuroanat; 2021 Nov; 117():102011. PubMed ID: 34384873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress.
    Luhach K; Kulkarni GT; Singh VP; Sharma B
    Autism Res; 2021 Nov; 14(11):2270-2286. PubMed ID: 34415116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.
    Bhateja DK; Dhull DK; Gill A; Sidhu A; Sharma S; Reddy BV; Padi SS
    Eur J Pharmacol; 2012 Jan; 674(1):33-43. PubMed ID: 22056833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.